Publikationen von 0000-0002-4302-3240
(ORCID: 0000-0002-4302-3240)

Harrer, Dennis Christoph , Schlierkamp-Voosen, Tim, Barden, Markus, Pan, Hong, Xydia, Maria, Herr, Wolfgang, Dörrie, Jan, Schaft, Niels und Abken, Hinrich (2025) Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion. Cells 14 (12), S. 901.

Harrer, Dennis Christoph , Eder, Matthias, Barden, Markus, Pan, Hong, Herr, Wolfgang und Abken, Hinrich (2024) Ectopic PU.1 Expression Provides Chimeric Antigen Receptor (CAR) T Cells with Innate Cell Capacities Including IFN-β Release. Cancers 16 (15), S. 2737.

Delacher, Michael , Schmidleithner, Lisa , Simon, Malte , Stüve, Philipp , Sanderink, Lieke , Hotz-Wagenblatt, Agnes, Wuttke, Marina , Schambeck, Kathrin , Ruhland, Brigitte , Hofmann, Veronika , Bittner, Sebastian , Ritter, Uwe , Pant, Asmita , Helbich, Sara Salome, Voss, Morten, Lemmermann, Niels A., Bessiri-Schake, Lisa, Bohn, Toszka, Eigenberger, Andreas , Menevse, Ayse Nur , Gebhard, Claudia , Strieder, Nicholas , Abken, Hinrich , Rehli, Michael , Huehn, Jochen, Beckhove, Philipp , Hehlgans, Thomas , Junger, Henrik , Geissler, Edward K. , Prantl, Lukas , Werner, Jens M. , Schmidl, Christian , Brors, Benedikt, Imbusch, Charles D. und Feuerer, Markus (2024) The effector program of human CD8 T cells supports tissue remodeling. Journal of Experimental Medicine 221 (2), e20230488.

Harrer, Dennis Christoph , Li, Sin-Syue, Kaljanac, Marcell, Barden, Markus, Pan, Hong und Abken, Hinrich (2023) Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges. Frontiers in Immunology 14.

Harrer, Dennis Christoph , Bezler, Valerie, Hartley, Jordan, Herr, Wolfgang und Abken, Hinrich (2023) IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities. Frontiers in Immunology 14.

Thomas, Simone und Abken, Hinrich (2023) CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells. Frontiers in Immunology 13.

Kaljanac, Marcell und Abken, Hinrich (2023) Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance. Transplantation 107 (1), S. 74-85.

Harrer, Dennis Christoph , Schenkel, Charlotte, Bezler, Valerie, Kaljanac, Marcell, Hartley, Jordan, Barden, Markus, Pan, Hong, Holzinger, Astrid, Herr, Wolfgang und Abken, Hinrich (2022) CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop. Cells 11 (23), S. 3839.

Holzinger, Astrid und Abken, Hinrich (2022) Treatment with Living Drugs: Pharmaceutical Aspects of CAR T Cells. Pharmacology 107 (9-10), S. 446-463.

Harrer, Dennis Christoph, Schenkel, Charlotte, Berking, Carola, Herr, Wolfgang, Abken, Hinrich , Dörrie, Jan und Schaft, Niels (2022) Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells. Cancers 14 (20), S. 5033. Volltext nicht vorhanden.

Bunse, Mario, Pfeilschifter, Janina, Bluhm, Julia, Zschummel, Maria, Joedicke, Jara J., Wirges, Anthea, Stark, Helen, Kretschmer, Vivien, Chmielewski, Markus, Uckert, Wolfgang, Abken, Hinrich , Westermann, Jörg, Rehm, Armin und Höpken, Uta E. (2021) CXCR5 CAR-T cells simultaneously target B cell non-Hodgkin’s lymphoma and tumor-supportive follicular T helper cells. Nature Communications 12 (1). Volltext nicht vorhanden.

Beckhove, Philipp , Edinger, Matthias, Feuerer, Markus, Gattinoni, Luca und Abken, Hinrich (2020) International Regensburg Center for Interventional Immunology (RCI) symposium on “Synthetic immunology and environment-adapted redirection of T cells”, 17–18 July, 2019, Regensburg, Germany. Cancer Immunology, Immunotherapy 69, S. 677-682.

Chmielewski, Markus und Abken, Hinrich (2020) TRUCKS, the fourth generation CAR T cells: current developments and clinical translation. Advances in Cell and Gene Therapy 3, e84.